Insider Sale by Friedl-Naderer Johanna (Chief Commercial Officer)
Trade Summary
6 days ago, Friedl-Naderer Johanna, serving as Chief Commercial Officer at Dyne Therapeutics, Inc. (DYN), sold 1,085 shares at $23.42 per share, for a total transaction value of $25,407.80. Following this transaction, Friedl-Naderer Johanna now holds 152,897 shares of DYN.
This sale represents a 0.70% decrease in Friedl-Naderer Johanna's stake in the company.
The trade was executed on Friday, September 4, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, September 8, 2026 at 4:15 PM ET, 4 days after the trade was made.
Dyne Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.
Trade Price
$23.42
Quantity
1,085
Total Value
$25,407.80
Shares Owned
152,897
Trade Date
6 days ago
SEC Filing Date
at 4:15 PM ET
Filed 4 days after trade
Discussion